Literature DB >> 11370617

Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas.

D B Evans1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11370617     DOI： 10.1016/s1091-255x(01)80002-0

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  19 in total

1.  Preoperative chemoradiation for patients with locally advanced adenocarcinoma of the pancreas.

Authors:  R White; C Lee; M Anscher; M Gottfried; R Wolff; M Keogan; T Pappas; H Hurwitz; D Tyler
Journal:  Ann Surg Oncol       Date:  1999 Jan-Feb       Impact factor: 5.344

2.  Combined modality therapy for stage II and stage III pancreatic carcinoma.

Authors:  A G Kamthan; J C Morris; J Dalton; J P Mandeli; M R Chesser; D Leben; A Cooperman; H W Bruckner
Journal:  J Clin Oncol       Date:  1997-08       Impact factor: 44.544

3.  The need for standardized pathologic staging of pancreaticoduodenectomy specimens.

Authors:  C A Staley; K R Cleary; J L Abbruzzese; J E Lee; F C Ames; C J Fenoglio; D B Evans
Journal:  Pancreas       Date:  1996-05       Impact factor: 3.327

4.  Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer.

Authors:  A W Blackstock; S A Bernard; F Richards; K S Eagle; L D Case; M E Poole; P D Savage; J E Tepper
Journal:  J Clin Oncol       Date:  1999-07       Impact factor: 44.544

5.  Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study.

Authors:  J P Hoffman; S Lipsitz; T Pisansky; J L Weese; L Solin; A B Benson
Journal:  J Clin Oncol       Date:  1998-01       Impact factor: 44.544

6.  Chemoradiotherapy as preoperative treatment in locally advanced unresectable pancreatic cancer patients: results of a feasibility study.

Authors:  E Bajetta; M Di Bartolomeo; S C Stani; S Artale; S B Ricci; F Bozzetti; V Mazzaferro; L Toffolatti; R Buzzoni
Journal:  Int J Radiat Oncol Biol Phys       Date:  1999-09-01       Impact factor: 7.038

7.  Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.

Authors:  D J Klaassen; J M MacIntyre; G E Catton; P F Engstrom; C G Moertel
Journal:  J Clin Oncol       Date:  1985-03       Impact factor: 44.544

Review 8.  Preoperative chemoradiation strategies for localized adenocarcinoma of the pancreas.

Authors:  D B Evans; P W Pisters; J E Lee; R J Bold; C Charnsangavej; N A Janjan; R A Wolff; J L Abbruzzese
Journal:  J Hepatobiliary Pancreat Surg       Date:  1998

9.  Neoadjuvant therapy for unresectable pancreatic adenocarcinoma.

Authors:  J M Jessup; G Steele; R J Mayer; M Posner; P Busse; B Cady; M Stone; R Jenkins; R Osteen
Journal:  Arch Surg       Date:  1993-05

10.  A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group.

Authors: 
Journal:  Ann Surg       Date:  1979-02       Impact factor: 12.969
View more
  7 in total

Review 1.  The role of neoadjuvant therapy in pancreatic cancer: a review.

Authors:  Suzanne Russo; John Ammori; Jennifer Eads; Jennifer Dorth
Journal:  Future Oncol       Date:  2016-02-01       Impact factor: 3.404

2.  Neoadjuvant therapy for pancreatic cancer: an ongoing debate.

Authors:  Suzanne Russo; M Wasif Saif
Journal:  Therap Adv Gastroenterol       Date:  2016-05-10       Impact factor: 4.409

3.  Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives.

Authors:  Hidehiro Tajima; Isamu Makino; Yoshinao Ohbatake; Shinichi Nakanuma; Hironori Hayashi; Hisatoshi Nakagawara; Tomoharu Miyashita; Hiroyuki Takamura; Tetsuo Ohta
Journal:  Oncol Lett       Date:  2017-04-07       Impact factor: 2.967

4.  Malignant mediastinal lymphadenopathy detected by endoscopic ultrasound and guided fine needle aspiration in patients with resectable pancreaticobiliary cancer.

Authors:  Praveer Rai; Vinod Kumar; Ram Naval Rao
Journal:  Indian J Gastroenterol       Date:  2017-05-29

Review 5.  Neoadjuvant strategies for pancreatic cancer.

Authors:  Francesco Polistina; Giuseppe Di Natale; Giorgio Bonciarelli; Giovanni Ambrosino; Mauro Frego
Journal:  World J Gastroenterol       Date:  2014-07-28       Impact factor: 5.742

6.  Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893, ISRCTN82191749).

Authors:  Michael Tachezy; Florian Gebauer; Cordula Petersen; Dirk Arnold; Martin Trepel; Karl Wegscheider; Phillipe Schafhausen; Maximilian Bockhorn; Jakob Robert Izbicki; Emre Yekebas
Journal:  BMC Cancer       Date:  2014-06-07       Impact factor: 4.430

7.  Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach?

Authors:  Carolin Zimmermann; Gunnar Folprecht; Daniel Zips; Christian Pilarsky; Hans Detlev Saeger; Robert Grutzmann
Journal:  Cancers (Basel)       Date:  2011-05-09       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.